The Discounted Cash Flow (DCF) valuation of Trinity Biotech PLC (TRIB) is (82.19) USD. With the latest stock price at 0.84 USD, the upside of Trinity Biotech PLC based on DCF is -9928.5%.
Based on the latest price of 0.84 USD and our DCF valuation, Trinity Biotech PLC (TRIB) is a sell. selling TRIB stocks now will result in a potential gain of 9928.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 7.1% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (150.70) - (59.34) | (82.19) |
| Upside | -18122.3% - -7196.8% | -9928.5% |